Leptomeningeal enhancement of the spinal cord in sarcoidosis

Abstract

View all access options for this article.

Hebel

Dubaniewicz-Wybieralska

Dubaniewicz

. Overview of neurosarcoidosis: Recent advances. J Neurol 2015; 262: 258–267.

Junger

Stern

Levine

et al . Intramedullary spinal sarcoidosis: Clinical and magnetic resonance imaging characteristics. Neurology 1993; 43: 333–337.

Kumar

Frohman

. Spinal neurosarcoidosis mimicking an idiopathic inflammatory demyelinating syndrome. Arch Neurol 2004; 61: 586–589.

Saleh

Saw

Marzouk

et al . Sarcoidosis of the spinal cord: Literature review and report of eight cases. J Natl Med Assoc 2006; 98: 965–976.

Sohn

Culver

Judson

et al . Spinal cord neurosarcoidosis. Am J Med Sci 2014; 347: 195–198.

Zalewski

Krecke

Weinshenker

et al . Central canal enhancement and the trident sign in spinal cord sarcoidosis. Neurology 2016; 87: 743–744.

Flanagan

Kaufmann

Krecke

et al . Discriminating long myelitis of neuromyelitis optica from sarcoidosis. Ann Neurol 2016; 79: 437–447.

Geraldes

Ciccarelli

Barkhof

et al . The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol 2018; 14(4): 199–213.

Absinta

Vuolo

Rao

et al . Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology 2015; 85: 18–28.

10.

Absinta

Cortese

Vuolo

et al . Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases. Neurology 2017; 88: 1439–1444.